Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2025-03-28 Fund Information / Fact…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
113年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table summarizing key financial ratios and metrics for the company 科妍 over three fiscal years (111年度, 112年度, 113年度). The data includes leverage ratios, liquidity ratios, operational efficiency, profitability, and cash flow metrics. The document is relatively short (1019 characters) and appears to be a summary or analysis of recent financial data rather than a full financial report. There is no indication that this is a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It also does not fit other categories like Audit Report, Management Report, or Investor Presentation. Given the concise nature and summary style, this document best fits the Fund Information / Factsheet (FS) category, which is for brief summaries of key company financials and facts.
2025-03-28 Chinese
114年3月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, and changes in capital such as capital increases and conversions of bonds to shares. It is a structured disclosure of share capital details rather than a narrative report or announcement. The document length is short (811 characters), but it is not merely an announcement of a report publication or a certification. It specifically details capital changes and share capital information, which aligns with the category for announcements regarding share issues or capital changes.
2025-03-12 Chinese
113年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief tabular disclosure of investment holdings and related financial figures for a specific quarter (113年4季, which corresponds to the fourth quarter of the 113th year in the Taiwanese calendar). It includes details such as investment company name, overseas subsidiary, shareholding percentage, original investment amount, investment balance, and recognized investment gains or losses. The document is very short (662 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is also not a meeting material, call transcript, or management report. Given the nature and length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-03-07 Chinese
113年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes specific financial figures, investment methods, and regulatory limits as per the Economic Ministry's Investment Commission. The document is relatively short (1289 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an annual or quarterly report, nor a management discussion or earnings release. It is a regulatory disclosure related to investment activities, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Capital/Financing Update or Annual Report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2025-03-07 Chinese
公告本公司董事會決議通過發行國內第三次無擔保轉換公 司債
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the board of directors' resolution to issue a domestic third unsecured convertible corporate bond. It includes details such as the board meeting date, bond name, issuance amount, terms, and related procedural information. This is an update on the company's financing activities, specifically about bond issuance. The document is short (1237 characters) and focuses on capital raising details rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP).
2025-03-06 Chinese
公告本公司除息基準日
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company (1786 科妍) regarding the ex-dividend date and dividend payment details. It includes specific dates for dividend distribution, ex-dividend trading, and related bond conversion periods. The document length is only 1005 characters, which is quite short and primarily provides dividend-related information rather than a full financial report or detailed analysis. According to the classification rules, announcements about dividend amounts and payment dates fall under the category 'Notice of Dividend Amount (DIV)'. Therefore, this document is best classified as a Notice of Dividend Amount.
2025-03-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.